AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential applications of AI in healthcare, and the ethical issues arising from its use, in a new briefing note, Artificial Intelligence (AI) in healthcare and research, published today.
The Master of Science Program in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf) in Bavaria, Germany - is accepting applications for entry in October 2018.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and US-based Emory Healthcare have launched a new remote Intensive Care Unit (eICU) monitoring program, based at the Royal Perth Hospital in Western Australia, focused on improving the outcomes of high risk patients and advancing the globalization of critical care.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing replacement parts in the laboratory, forms a key part of this research. The parts can be used to replace defective cells and tissues in the body and restore their normal functioning.
Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has developed an innovative, easy to use device to treat positional obstructive sleep apnea and positional snoring. Financial details of the transaction were not disclosed.
It's a neuroscientist's dream: being able to track the millions of interactions among brain cells in animals that move about freely, behaving as they would under natural circumstances. New technology developed at The Rockefeller University represents a big step toward realizing that goal.
Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR 3.2 billion on a comparable basis. Despite continuing negative currency effects, the profit margin adjusted for non-recurring effects increased by 90 basis points to 17.4 percent, while adjusted profit was stable at EUR 560 million compared to the second quarter of 2017.
Body-worn sensors used at home and in clinic by people with mild Alzheimer's to assess walking could offer a cost-effective way to detect early disease and monitor progression of the illness. A pilot study involving Newcastle University, UK, has revealed low-cost wearable devices could improve clinical trial efficiency and encourage research investment. Identification of clinical biomarkers, such as changes in walking characteristics and behaviours, are known to be important factors when looking at early warning signs of dementia.
As the R&D Digital Lead, you will be responsible for partnering across all GSK Consumer Health categories to develop a strategic pipeline of digital healthcare innovation. This will include pioneering new, creative approaches to develop intuitive digital diagnostics and therapeutics, as well as evaluating digital devices/sensors/apps either marketed or in various stages of development. You will be a key contributor to the R&D innovation strategy to deliver digital innovation including: devices, wearables, software, and apps.